跳至主要内容
临床试验/NCT00866229
NCT00866229Unknown4 期

Efficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in SLE Patients With Corticosteroid Therapy and High LDL Cholesterol Level

Ramathibodi Hospital2 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2008年4月最近更新:
适应症
相关药物

试验速览

阶段
4 期
入组人数
140
试验地点
2
主要终点
Percentage reduction of LDL Cholesterol level

研究概览

简要总结

Early statin therapy in SLE patients that have high cholesterol level and other atherosclerosis risk should reduce atherosclerosis and coronary artery events in later course of disease. By the way, statin is used in restricted groups of rheumatologists due to awareness of side effects; myositis and hepatitis, that are frequently found in SLE patients more so than other groups of atherosclerosis patients and reporting data of autoimmune diseases that occur after statin use.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • SLE patients that on prednisolone more than 30 mg/day
  • Normal liver faction: AST and ALT < 80 mg/dl
  • Normal muscle enzyme : CPK < 100 U/L
  • LDL cholesterol level > 100 mg/dl

排除标准

  • Patients that was treated with pulse methylprednisolone or corticosteroid equivalent to prednisolone > 1mg/kg/day at screening.
  • Statin allergy
  • On statin treatment before screening
  • On cyclosporine, antifugal (azole group), antibiotics (macrolide group), rifampicin, warfarin, phenytoin
  • Pregnancy
  • Abnormal liver function: AST or ALT > 80 mg/dl
  • Abnormal muscle enzyme : CPK > 300 U/L

结局指标

主要结局

Percentage reduction of LDL Cholesterol level

时间窗: 6 and 12 weeks

次要结局

  • Proportion of patients that have transminitis, myositis or active SLE(6,12, 18 and 24 weeks)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验